Intracerebral inoculation of lymphocytic choriomeningitis (LCM) virus into 4-day-old suckling rats results in a profound destructive lesion of the cerebellum (1, 9) . This pathology is associated with a nonlethal transient choriomeningitis. In the mouse, the natural host, intracerebral inoculation of LCM virus results either in an asymptomatic central nervous system infection when given to newborns or in an acute fatal convulsive diathesis with no morphological evidence of central nervous system parenchymal involvement when administered to adults (6) . Thus, the pathological picture produced in rats differs sharply from the classical responses of the mouse to LCM virus infection.
Considering the well established immunological nature of LCM virus-induced disease in mice (4) (5) (6) , the present study was conducted to determine whether the disease in rats also is immune-mediated or whether it is due to a cytocidal effect of LCM virus on the granule cell population.
MATERIALS AND METHODS
The animals, virus, and methods for virus titration, complement-fixation tests, immunofluorescent staining, and histological procedures have been described previously (9) .
Anti-lymphoid serum (ALS). The method of Levey and Medawar (7) was used. Thymus cells, obtained from 6-to 14-week-old rats, were suspended in minimal Eagle medium containing L-glutamine, penicillin, and streptomycin. New Zealand white rabbits, each about 2.5 kg in weight, were injected intravenously with 4 
RESULTS
Neuropathological observations. ALS treatment of rats infected intracerebrally at 4 days of age with LCM virus prevented the development of the severe necrotic lesion of the cerebellum which occurred in animals not given this immunosuppressive regimen (Fig. 1) . No clinical signs of disease were apparent in the ALS treatment groups, whereas animals in all the other groups became ataxic 9 to 14 days after infection. A minimal choriomeningitis, first apparent 5 days after inoculation, was seen in animals given ALS and was resolved within the following 10 days. This was in contrast to the severe cellular infiltrate of mononuclear cells seen in the choroid plexuses and leptomeninges of non-immunosuppressed animals during the same period. Both ALS preparations proved to be equally effective in abrogating the cerebellar pathology.
In order to determine whether pathological alterations would develop with the cerebellum after cessation of immunosuppression, rats were followed histologically for 6 months after termination of ALS. No lesions were found in the ALS-treated animals.
Immunofluorescent observations. The distribution of LCM viral antigen in ALS-treated animals, as assessed by immunofluorescent staining, was similar to that found in the NRS-treated group. However, in contrast to rats given only virus in which the number of fluorescing cells were markedly reduced beginning 2 weeks after infection, immunosuppressed rats continued to exhibit intensely staining cells in the cerebellum, choroid plexus, hippocampal dentate gyrus, and olfactory bulb. After conclusion of the ALS treatment, viral antigen could be detected in diminishing amounts in these areas. However, even 7. months after infection, fluorescence could still be detected in small numbers of cells throughout the cerebral cortex, diencephalon, midbrain, and cerebellar inner granular cell layer.
Virological studies. The growth curves of virus in the brains of rats receiving ALS and in those receiving NRS were the same over the first postinoculation week (Table 1) . Brain virus titers in the NRS-treated animals declined after this time, reaching minimal levels by 50 days after infection. On the other hand, titers remained high in the ALS-treated animals, gradually waning after discontinuance of immunosuppression, with trace levels of infective virus detectable as long as 6 months after inoculation.
Viremia was minimal and transient in the rats given NRS. In contrast, the ALS-treated groups evidenced significant levels of virus in their blood for at least a month after termination of immunosuppression.
Complement-fixing antibody. As in earlier studies, the nonsuppressed LCM virus-infected rats developed observable complement-fixing antibodies by the third week following intracerebral inoculation (Table 1) . However, no antibody was detected in the rats given ALS until 3 months after the end of the serum treatment.
DISCUSSION
Intracerebral inoculation of 4-day-old rats with LCM virus induces a profound cerebellar necrosis. Although the development of this pathology is associated with a severe choriomeningitis, there is a marked absence of more than a minimal inflammation evident by light microscopy within the evolving lesion. Such an observation led, initially, to the assumption that the lesion in the rat was due to a direct cytopathic effect of the virus upon the neuronal cells. The results of this study, however, clearly indicate that the cerebellar destruction is a consequence of immunopathological mechanisms, since immunosuppression prevented development of the lesion in the presence of persistent infection of the neural parenchyma.
ALS treatment markedly slowed virus clearance from the brain, and cessation of treatment was followed by a gradual decline in brain virus titers. Furthermore, suppressed rats had more pronounced viremias. These observations indicate that immune mechanisms play a role in LCM virus clearance. The fact that virus titers gradually decrease concomitantly with the evolution of the circulating antibody response suggests that antibody may contribute to this phenomenon. The simultaneous occurrence of viral clearance from the central nervous system of mice (2) or of rats (unpublished observations) neonatally infected with LCM virus and the appearance in the brain of bound immunoglobin supports this possibility.
At least two possible reasons exist for the failure of a cerebellar lesion to develop after the termination of the ALS regimen. The establishment of an elevated viremia early in the infection and its persistence resulting from ALS treatment could lead to a transient state of "high zone" immunological unresponsiveness (8) in which virus-specific immune induction is either precluded or masked by the excessive levels of circulating viral antigen(s). As shown 
